Monoclonal antibody can effectively reverse bleeding complications linked to ticagrelor
An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients with acute coronary syndromes, prior…